Efficacy of empagliflozin as adjunctive therapy to citalopram in major depressive disorder: a randomized double-blind, placebo-controlled clinical trial
By activating GLP-1 receptors, tirzepatide enhances glucose-dependent insulin secretion from pancreatic beta cells, suppresses inappropriate glucagon release, slows gastric emptying, and reduces appetite through central nervous system pathways
By enhancing insulin secretion and improving insulin sensitivity, Ozempic helps lower blood sugar levels and improve overall glycemic control
How to Prevent Nutritional Deficiencies on GLP-1 RAs The great news is that with a few mindful steps, you can prevent most nutritional deficiencies while on GLP-1 RA therapy
GLP-1 reduces blood glucose levels by promoting glucose-dependent insulin secretion from pancreatic cells, suppressing glucagon release from pancreatic cells, and blocking hepatic gluconeogenesis